Grifols SA
GRFS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001438569
No open-market purchases or sales by Grifols SA insiders were filed in the last 90 days; 164 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Grifols SA changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 156 | 3 | 181 | +28 |
| Shares | 145.8M | 2.00M | 140.2M | −3.59M (−2.5%) |
| Value | $1.32B | $18.0M | $1.40B | +$96.1M (+7.4%) |
3 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (40)
Institutions that held Grifols SA at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (12)
Institutions that held Grifols SA at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Point72 (DIFC) Ltd | 1,017,200 | $9.20M |
| Saba Capital Management, L.P. | 269,686 | $2.44M |
| Anthracite Investment Company, Inc. | 86,688 | $783.7K |
| Vestmark Advisory Solutions, Inc. | 45,820 | $414.2K |
| Susquehanna International Group, LLP | 16,984 | $153.5K |
| Skopos Labs, Inc. | 4,490 | $40.6K |
| Group One Trading, L.P. | 3,110 | $28.1K |
| Simplex Trading, LLC | 2,874 | $25.0K |
| MAI Capital Management | 792 | $7.16K |
| Sierra Ocean, LLC | 457 | $4.13K |
| Geneos Wealth Management Inc. | 110 | $994 |
| Arlington Trust Co LLC | 95 | $859 |
Not filed for Q3 2025 yet (3)
Institutions that held Grifols SA at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 1,940,000 | $17.5M |
| Atlas Capital Advisors LLC | 53,785 | $486.2K |
| First Horizon Advisors, Inc. | 2,498 | $22.6K |